Misplaced Pages

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 13:32, 15 November 2011 (Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank', 'CASNo').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Dazoxiben

Identifiers
3D model (JSmol)	Interactive image
ChEMBL	ChEMBL267473
ChemSpider	47885
DrugBank	DB03052
PubChem CID	53001
CompTox Dashboard (EPA)	DTXSID9045639
InChI InChI=1S/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)Key: XQGZSYKGWHUSDH-UHFFFAOYSA-N InChI=1/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)Key: XQGZSYKGWHUSDH-UHFFFAOYAY
SMILES O=C(O)c2ccc(OCCn1ccnc1)cc2
Properties
Chemical formula	C12H12N2O3
Molar mass	232.2 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Y verify (what is  ?) Infobox references

Dazoxiben is an orally active thromboxane synthase inhibitor. It has shown a significant clinical improvement in patients with Raynaud's syndrome.

References

1. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6337601, please use {{cite journal}} with |pmid=6337601 instead.
2. Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6337601, please use {{cite journal}} with |pmid=6337601 instead.

• Drugs